Bernard J. Zovighian, CEO at Edwards Lifesciences Corp (EW), sold 47,780 shares at $77.13 ($3.4M) on 2026-02-12, disclosed to the SEC on 2026-02-13.
Open-market sale of $3.4M EW by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.61 | 19,898 | $1.5M | 44.3% |
| 2 | $76.61 | 19,898 | $1.5M | 44.3% |
| 3 | $77.13 | 2,532 | $195K | 5.7% |
| 4 | $77.13 | 2,532 | $195K | 5.7% |
| 5 | $0.00 | 2,920 | $0 | 0.0% |
| Total | $71.98 avg | 47,780 |
| $3.4M |
| 100% |
| Filing → |
| EW | SELL | 2026-05-12 | $2.8M | — | Filing → |
| EW | SELL | 2025-12-10 | $4.3M | — | Filing → |
| EW | SELL | 2025-06-03 | $2.6M | — | Filing → |